Contents

Search

Lutonix 035 drug coated balloon percutaneous transluminal angioplasty catheter (Lutonix DCB)

paclitaxel-coated angioplasty balloon catheter Indications: - peripheral arterial disease - *FDA-approved for superficial femoral artery & popliteal artery occlusion [1] Contraindications: - contraindicated in patients with hypersensitivity to paclitaxel - apparent lack of benefit for women

Related

angioplasty; balloon angioplasty

General

angioplasty catheter

References

  1. FDA News Release. October 10, 2014 FDA approves first drug-coated angioplasty balloon catheter to treat vascular disease http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418455.htm